Evaluation of Vancomycin Dosing and Monitoring in Adult Medicine Patients
- 1 June 2012
- journal article
- research article
- Published by SAGE Publications in Hospital Pharmacy
- Vol. 47 (6) , 451-459
Abstract
Purpose: To assess the clinical impact of a vancomycin dosing protocol and monitoring tool on initial dose, dosing interval, and trough concentrations in adult medicine patients. Methods: This was a retrospective chart review of adult medicine patients who received at least one dose of vancomycin and were admitted during the pre-implementation period, February 1 to April 2009, or during the post-implementation period, June 1 to October 31, 2009. All outcomes for patients in the pre-implementation group were compared to those in the post-implementation group. The primary outcomes were frequency of appropriate initial vancomycin dose and dosing interval. The secondary outcomes included frequency of appropriate initial vancomycin trough concentrations, mean number of levels drawn per patient, and mean duration of therapy. Results: A total of 450 patients were identified, with 225 patients in each study group. Patients with an appropriate initial vancomycin dose significantly increased in the post-implementation group (56% vs 40%; P < .001). The number of patients with an appropriate original dosing interval (67% vs 63%; P = 0.32), appropriate initial trough concentration (44% vs 45%; P = 0.89), mean number of levels drawn (1.9 vs 2.1; P = 0.56), and duration of therapy (4.9 vs 5.0; P = 0.77) was similar between the 2 groups. Conclusions: The implementation of a vancomycin empiric dosing protocol and monitoring tool had a significant impact on the initial dose. Further education regarding vancomycin dosing and monitoring is warranted to improve initial dosing interval, initial trough concentration, number of levels drawn, and duration of therapy.Keywords
This publication has 15 references indexed in Scilit:
- Implementation and evaluation of vancomycin nomogram guidelines in a computerized prescriber-order-entry systemAmerican Journal of Health-System Pharmacy, 2010
- Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrationsJournal of Antimicrobial Chemotherapy, 2009
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsAmerican Journal of Health-System Pharmacy, 2009
- Observations on vancomycin use in U.S. hospitalsAmerican Journal of Health-System Pharmacy, 2007
- Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemiaJournal of Antimicrobial Chemotherapy, 2006
- Vancomycin: A 50-Year ReassessmentClinical Infectious Diseases, 2006
- Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infectionsJournal of Antimicrobial Chemotherapy, 2005
- Staphylococcus aureus with Reduced Susceptibility to VancomycinClinical Infectious Diseases, 2004
- Treatment Outcomes for Serious Infections Caused by Methicillin‐ResistantStaphylococcus aureuswith Reduced Vancomycin SusceptibilityClinical Infectious Diseases, 2004
- Determinants of Vancomycin Use in Adult Intensive Care Units in 41 United States HospitalsClinical Infectious Diseases, 1999